Muna Therapeutics Announces CEO Transition as Clinical Pipeline Advances

Go back to Muna Therapeutics Announces CEO Transition as Clinical Pipeline Advances
(NASDAQ: ITOS) Delayed: 10.15 --0 (-0%)
Previous Close $10.15    52 Week High
Open $10.15    52 Week Low
Day High $10.15    P/E N/A 
Day Low $10.15    EPS
Volume 1,428,455